Blog
RSS FeedPosted by Michael Wonder on 11 Oct 2021
Belgium may remove step between paying doctors and reimbursement
8 October 2021 - Doctors and dentists could soon choose to only charge patients for co-payments – the non-refundable part ...
Posted by Michael Wonder on 11 Oct 2021
Minister for Health announces HSE approval to reimburse Zolgensma (onasemnogene abeparvovec) as part of a joint BeNeLuxA collaboration
8 October 2021 - Following the first joint agreement on the price of a drug between Belgium, Ireland and the ...
Posted by Michael Wonder on 05 Jul 2021
New cancer drugs are expensive and often ineffective
5 July 2021 - Many of the new cancer drugs coming onto the market in Belgium are too expensive, and ...
Posted by Michael Wonder on 18 May 2021
Belgium seeks to encourage generic drugs with new prescription reimbursement structure
18 May 2021 - The federal government has decided to increase the percentage by which generic drugs will be reimbursed, ...
Posted by Michael Wonder on 07 May 2021
High Council for Health calls for reimbursement for ADHD medication
5 May 2021 - The High Council for Health has issued a formal opinion calling for medication used in the treatment ...
Posted by Michael Wonder on 09 Sep 2020
Evaluation of precision medicine assessment reports of the Belgian health care payer to inform reimbursement decisions
7 September 2020 - Precision medicines rely on companion diagnostics to identify patient subgroups eligible for receiving the pharmaceutical product. ...
Posted by Michael Wonder on 15 Oct 2019
Flemish Alzheimerliga wants to maintain reimbursement of Alzheimer’s disease medication
14 October 2019 - The Flemish Alzheimerliga, that represents patients with Alzheimer’s disease and their families, is against the National ...
Posted by Michael Wonder on 18 Sep 2019
Baby Pia: almost 1 million Belgians pay for life-saving drug
18 September 2019 - More than 950,000 Belgians have responded to a couple seeking €1.9m ($2m; £1.7m) to cover the ...